相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Interindividual and Regional Variability in Drug Transporter Abundance at the Human Blood-Brain Barrier Measured by Quantitative Targeted Proteomics
Sarah Billington et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
ABCG2/BCRP: variants, transporter interaction profile of substrates and inhibitors
Zsolt Safar et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2019)
Proteomic Quantification of Human Blood-Brain Barrier SLC and ABC Transporters in Healthy Individuals and Dementia Patients
Zubida M. Al-Majdoub et al.
MOLECULAR PHARMACEUTICS (2019)
Brain Delivery of a Potent Opioid Receptor Agonist, Biphalin during Ischemic Stroke: Role of Organic Anion Transporting Polypeptide (OATP)
Thamer H. Albekairi et al.
PHARMACEUTICS (2019)
Association of statin pretreatment with collateral circulation and final infarct volume in acute ischemic stroke patients: A meta-analysis
Konark Malhotra et al.
ATHEROSCLEROSIS (2019)
Honey flavonoids inhibit hOATP2B1 and hOATP1A2 transporters and hOATP-mediated rosuvastatin cell uptake in vitro
Lucie Navratilova et al.
XENOBIOTICA (2018)
Hyperuricemia enhances intracellular urate accumulation via down-regulation of cell-surface BCRP/ABCG2 expression in vascular endothelial cells
Hisakazu Komori et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2018)
Organic Anion Transporting Polypeptide 1a4 is Responsible for the Hepatic Uptake of Cardiac Glycosides in Mice
Junichi Takano et al.
DRUG METABOLISM AND DISPOSITION (2018)
Simultaneous Assessment of Transporter-Mediated Drug-Drug Interactions Using a Probe Drug Cocktail in Cynomolgus Monkey
Rachel E. Kosa et al.
DRUG METABOLISM AND DISPOSITION (2018)
Evaluation of Organic Anion Transporter 1A2-knock-in Mice as a Model of Human Blood-brain Barrier
Yamato Sano et al.
DRUG METABOLISM AND DISPOSITION (2018)
A new era for stroke therapy: Integrating neurovascular protection with optimal reperfusion
Ligen Shi et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2018)
Functional Expression of Organic Anion Transporting Polypeptide 1a4 Is Regulated by Transforming Growth Factor-β/Activin Receptor-like Kinase 1 Signaling at the Blood-Brain Barrier
Wazir Abdullahi et al.
MOLECULAR PHARMACOLOGY (2018)
Sex-specific differences in organic anion transporting polypeptide 1a4 (Oatp1a4) functional expression at the blood-brain barrier in Sprague-Dawley rats
Hrvoje Brzica et al.
FLUIDS AND BARRIERS OF THE CNS (2018)
Prediction of the Pharmacokinetics of Pravastatin as an OATP Substrate Using Plateable Human Hepatocytes With Human Plasma Data and PBPK Modeling
Jialin Mao et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2018)
Bone morphogenetic protein-9 increases the functional expression of organic anion transporting polypeptide 1a4 at the blood-brain barrier via the activin receptor-like kinase-1 receptor
Wazir Abdullahi et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2017)
In Vitro Intrinsic Permeability: A Transporter-Independent Measure of Caco-2 Cell Permeability in Drug Design and Development
Linda Fredlund et al.
MOLECULAR PHARMACEUTICS (2017)
Multiple blood-brain barrier transport mechanisms limit bumetanide accumulation, and therapeutic potential, in the mammalian brain
Kerstin Roemermann et al.
NEUROPHARMACOLOGY (2017)
Expression and activity of multidrug resistance proteins in mature endothelial cells and their precursors: A challenging correlation
Agnieszka Krawczenko et al.
PLOS ONE (2017)
Utilization of Statins Beyond the Initial Period After Stroke and 1-Year Risk of Recurrent Stroke
Meng Lee et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Functional Expression of P-glycoprotein and Organic Anion Transporting Polypeptides at the Blood-Brain Barrier: Understanding Transport Mechanisms for Improved CNS Drug Delivery?
Wazir Abdullahi et al.
AAPS JOURNAL (2017)
Influence of Statin Pretreatment on Initial Neurological Severity and Short-Term Functional Outcome in Acute Ischemic Stroke Patients: The Fukuoka Stroke Registry
Hiromi Ishikawa et al.
CEREBROVASCULAR DISEASES (2016)
No major effects of vitamin D3 (1,25 dihydroxyvitamin D3) on absorption and pharmacokinetics of folic acid and fexofenadine in healthy volunteers
Gerd A. Kullak-Ublick et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Role of OATP2A1 in PGE2 secretion from human colorectal cancer cells via exocytosis in response to oxidative stress
Taku Kasai et al.
EXPERIMENTAL CELL RESEARCH (2016)
Combination of Thrombolysis and Statins in Acute Stroke Is Safe Results of the STARS Randomized Trial (Stroke Treatment With Acute Reperfusion and Simvastatin)
Joan Montaner et al.
STROKE (2016)
Genome-wide RNAi screen reveals ALK1 mediates LDL uptake and transcytosis in endothelial cells
Jan R. Kraehling et al.
NATURE COMMUNICATIONS (2016)
Neuroprotective effects and dynamic expressions of MMP9 and TIMP1 associated with atorvastatin pretreatment in ischemia-reperfusion rats
Xiao Fang et al.
NEUROSCIENCE LETTERS (2015)
Solute Carrier Family of the Organic Anion-Transporting Polypeptides 1A2-Madin-Darby Canine Kidney II: A Promising In Vitro System to Understand the Role of Organic Anion-Transporting Polypeptide 1A2 in Blood-Brain Barrier Drug Penetration
Houfu Liu et al.
DRUG METABOLISM AND DISPOSITION (2015)
Signaling Pathways that Regulate Basal ABC Transporter Activity at the Blood-Brain Barrier
David S. Miller et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Hypoxia/reoxygenation stress signals an increase in organic anion transporting polypeptide 1a4 (Oatp1a4) at the blood-brain barrier: relevance to CNS drug delivery
Brandon J. Thompson et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2014)
Utility of Oatp1a/1b-Knockout and OATP1B1/3-Humanized Mice in the Study of OATP-Mediated Pharmacokinetics and Tissue Distribution: Case Studies with Pravastatin, Atorvastatin, Simvastatin, and Carboxydichlorofluorescein
J. William Higgins et al.
DRUG METABOLISM AND DISPOSITION (2014)
Modeling Cyclosporine A Inhibition of the Distribution of a P-Glycoprotein PET Ligand, 11C-Verapamil, into the Maternal Brain and Fetal Liver of the Pregnant Nonhuman Primate: Impact of Tissue Blood Flow and Site of Inhibition
Alice Ban Ke et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Quantitative Targeted Absolute Proteomic Analysis of Transporters, Receptors and Junction Proteins for Validation of Human Cerebral Microvascular Endothelial Cell Line hCMEC/D3 as a Human Blood-Brain Barrier Model
Sumio Ohtsuki et al.
MOLECULAR PHARMACEUTICS (2013)
P-Glycoprotein, Breast Cancer Resistance Protein, Organic Anion Transporter 3, and Transporting Peptide 1a4 during Blood-Brain Barrier Maturation: Involvement of Wnt/β-Catenin and Endothelin-1 Signaling
Rania Harati et al.
MOLECULAR PHARMACEUTICS (2013)
Role of Drug Efflux and Uptake Transporters in Atazanavir Intestinal Permeability and Drug-Drug Interactions
Olena Kis et al.
PHARMACEUTICAL RESEARCH (2013)
Localization of organic anion transporting polypeptide (Oatp) 1a4 and Oatp1c1 at the rat blood-retinal barrier
Shin-ichi Akanuma et al.
FLUIDS AND BARRIERS OF THE CNS (2013)
Targeted Drug Delivery to Treat Pain and Cerebral Hypoxia
Patrick T. Ronaldson et al.
PHARMACOLOGICAL REVIEWS (2013)
Inflammatory Pain Signals an Increase in Functional Expression of Organic Anion Transporting Polypeptide 1a4 at the Blood-Brain Barrier
Patrick T. Ronaldson et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Use of Transporter Knockdown Caco-2 Cells to Investigate the In Vitro Efflux of Statin Drugs
Jibin Li et al.
DRUG METABOLISM AND DISPOSITION (2011)
Influence of the flavonoids apigenin, kaempferol, and quercetin on the function of organic anion transporting polypeptides 1A2 and 2B1
Kathrin Mandery et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Functional Characterization of Mouse Organic Anion Transporting Peptide 1a4 in the Uptake and Efflux of Drugs Across the Blood-Brain Barrier
Atsushi Ose et al.
DRUG METABOLISM AND DISPOSITION (2010)
Differential inhibition of murine Bcrpl/Abcg2 and human BCRP/ABCG2 by the mycotoxin fumitremorgin C
Lucia Gonzalez-Lobato et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Intestinal Absorption of HMG-CoA Reductase Inhibitor Pravastatin Mediated by Organic Anion Transporting Polypeptide
Yoshiyuki Shirasaka et al.
PHARMACEUTICAL RESEARCH (2010)
Expression and transcriptional regulation of ABC transporters and cytochromes P450 in hCMEC/D3 human cerebral microvascular endothelial cells
Sandrine Dauchy et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Transforming growth factor-β signaling alters substrate permeability and tight junction protein expression at the blood-brain barrier during inflammatory pain
Patrick T. Ronaldson et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2009)
Atorvastatin extends the therapeutic window for tPA to 6 h after the onset of embolic stroke in rats
Li Zhang et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2009)
Structure-activity relationship study of bone morphogenetic protein (BMP) signaling inhibitors
Gregory D. Cuny et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Bone morphogenetic protein-9 is a circulating vascular quiescence factor
Laurent David et al.
CIRCULATION RESEARCH (2008)
Thyroid hormone transport and metabolism by organic anion transporter 1C1 and consequences of genetic variation
Wendy M. van der Deure et al.
ENDOCRINOLOGY (2008)
In vitro biliary clearance of angiotensin II receptor blockers and 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors in sandwich-cultured rat hepatocytes: Comparison with in vivo biliary clearance
Koji Abe et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Naringin is a major and selective clinical inhibitor of organic anion-transporting polypeptide 1A2 (OATP1A2) in grapefruit juice
D. G. Bailey et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Effect of OATP1B transporter inhibition on the pharmacokinetics of atorvastatin in healthy volunteers
Y. Y. Lau et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
HIV-1 viral envelope glycoprotein gp120 triggers an inflammatory response in cultured rat Astrocytes and regulates the functional expression of P-glycoprotein
Patrick T. Ronaldson et al.
MOLECULAR PHARMACOLOGY (2006)
Predominant contribution of OATP1B3 to the hepatic uptake of telmisartan, an angiotensin II receptor antagonist, in humans
Naoki Ishiguro et al.
DRUG METABOLISM AND DISPOSITION (2006)
Drug and bile acid transporters in rosuvastatin hepatic uptake: Function, expression, and pharmacogenetics
Richard H. Ho et al.
GASTROENTEROLOGY (2006)
ABCC drug efflux pumps and organic anion uptake transporters in human gliomas and the blood-tumor barrier
H Bronger et al.
CANCER RESEARCH (2005)
Involvement of BCRP (ABCG2) in the biliary excretion of pitavastatin
M Hirano et al.
MOLECULAR PHARMACOLOGY (2005)
Polymorphisms in human organic anion-transporting polypeptide 1A2 (OATP1A2) - Implications for altered drug disposition and central nervous system drug entry
W Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Interactions of human P-glycoprotein with simvastatin, simvastatin acid, and atorvastatin
JH Hochman et al.
PHARMACEUTICAL RESEARCH (2004)
Overexpression of multiple drug resistance genes in endothelial cells from patients with refractory epilepsy
SM Dombrowski et al.
EPILEPSIA (2001)
HMG-CoA reductase inhibitors and P-glycoprotein modulation
K Bogman et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
分享论文
